StimCell Energetics Inc., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, metabolic syndrome, neuropathy, and kidney functions in the United States. It develops and manufactures the eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and the eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. The company also develops eBalance Home and eBalance Pro System for temporary relief of the shoulder, waist, back, neck, upper and lower extremities (arms and legs). The company was formerly known as Cell MedX Corp. and changed its name to StimCell Energetics Inc. in November 2024. StimCell Energetics Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.
Часто задаваемые вопросы
В каком секторе работает STME (STME)?
STME относится к сектору Прочее.
Какова текущая цена акций STME (STME)?
По последним данным, цена акций STME составляет 0,22 $, предыдущее закрытие — 0,15 $. За последнюю торговую сессию акции STME выросли на 0,08 $, что соответствует росту на 53,07%.
Выплачивает ли STME (STME) дивиденды?
Нет, STME не выплачивает дивиденды.
Какой бета-коэффициент (волатильность) у STME (STME)?
У компании STME бета 46.212, что свидетельствует о крайне высокой волатильности по сравнению с рынком
